Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Medicine

Microbiology

Pathology

Show all topics

DOI

10.1101/2023.09.24.558921

License

CC-BY-NC-ND

Other Formats

PDF